CERBA HEALTHCARE ENTERS AGREEMENT TO ACQUIRE VIROCLINICS-DDL EXPANDING AND TRANSFORMING ITS OFFERING IN CLINICAL TRIALS

Acquisition illustrates the Group’s strategy to strengthen its position in the entire value chain of diagnosis and stresses the pivotal role of clinical trial services. It offers Viroclinics-DDL a broader range of capabilities in its specialty services, and a unique entry into new markets in North America, Asia, and Africa.